FUSION POLYPEPTIDES AND USES THEREOF

The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors c...

Full description

Saved in:
Bibliographic Details
Main Authors SCHEERER, Nina Alexandra, JÖRISSEN, Hannah, LEINEWEBER, Kirsten, WILMEN, Andreas
Format Patent
LanguageEnglish
French
German
Published 04.11.2015
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
Bibliography:Application Number: EP20130814133